Moreover, in our in vivo study, the silence of TXNIP markedly decreased the expression level of NLRP3/caspase-1 pathway-related genes and alleviated the damage of the kidney under the sepsis conditions, which is similar with the result of miR-30c-5p treatment. The gene discussed is TXNIP; the disease is Sepsis.